Skip to main content
OpenTrials

Clinical trial condition

Pathologic Complete Response

Explore clinical trials studying Pathologic Complete Response. Study availability and eligibility vary by location and protocol.

92 public trials 30 recruiting studies
Refine in advanced search Browse all conditions

Pathologic Complete Response trial results

Recruiting

40.2Gy Versus 49.2Gy Radiotherapy in Low-Risk Target Volume for Chemosensitive Stage II Nasopharyngeal Carcinoma

NCT07328854

Conditions
Carcinoma, Disease Attributes, Disease Progression, +16 more
Locations
  • Anhui Provincial Cancer Hospital Hefei, Anhui, China
  • Fujian Cancer Hospital Fuzhou, Fujian, China
  • Sun Yat-sen University cancer center Guangzhou, Guangdong, China
  • the Affiliated Cancer Hospital of Guangzhou Medical University Guangzhou, Guangdong, China
View all 15 locations
View Trial Details
Recruiting

Reduced-dose Versus Conventional-dose Intensity-modulated Radiation Therapy for Locally Advanced Nasopharyngeal Carcinoma With Remission After Induction Chemotherapy and Immunotherapy

NCT07328841

Conditions
Carcinoma, Disease Attributes, Disease Progression, +17 more
Locations
  • The Fifth Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China
  • Cancer Center of Guangzhou Medical University Guangzhou, Guangdong, China
  • Sun Yat-sen University cancer center Guangzhou, Guangdong, China
  • The Second Affiliated Hospital of Sun Yat-sen University (SYSU) Guangzhou, Guangdong, China
View Trial Details
Recruiting

Clinical Validation and Benchmarking of Top Performing ctDNA Diagnostics - Stage III NSCLC

NCT06111807

Conditions
Disease Attributes, Disease Progression, Hypersensitivity, +14 more
Locations
  • Centre Hospitalier Universitaire de Nice Nice, France
  • Antoine Lacassagne Center Nice, France
  • Department of thoracic oncology- LungenClinic Großhansdorf Großhansdorf, Grosshansdorf, Germany
  • Isala Zwolle, Overijssel, Netherlands
View Trial Details

Related conditions